IPO and US public markets

We work with companies with $15M+ annual USD revenue and strong EBITDA or a credible path to profitability. Below that, alternative paths (private capital, regional listings) usually make more sense.

For most growth-oriented Uzbek and CIS companies, US markets offer superior depth, liquidity, and valuation multiples. London and Hong Kong can suit specific businesses but rarely produce the same outcome.

The deepest institutional investor base in the world, USD-denominated capital access, brand and credit visibility, and a permanent public currency for growth, acquisitions, and secondary offerings.

Governance and audit readiness, F-1 / S-1 filing, SEC review, roadshow, pricing, and listing. Preparation typically takes 12–18 months; the formal process runs four to six months.

12–24 months from decision to first trade, depending on readiness. Companies with clean financials, governance, and IR programmes move faster.

Registration and periodic reporting (10-K / 20-F, 10-Q, 8-K), disclosure controls, and Sarbanes-Oxley obligations for internal control over financial reporting.

Board composition, independence, committees (audit, comp, nominating), controls, policies, and disclosure — all built to public-company standards well before listing.

Costs vary widely — underwriter fees are typically the largest single line, with legal, audit, and printer costs adding meaningfully. Preparation costs (audit, controls, governance) are additional.

Reverse takeovers (RTOs), SPAC mergers, direct listings, and Rule 144A private placements to institutional investors. Each has different economics, timelines, and control implications.